Underweight Position in Vertiv Holdings Weighs on Fidelity Growth Strategies Funds Q1 Results The JM SJM Reports Strong Q1 2026 Revenue NA EPS Beats Gold at 4500 Fuels a Grassroots Gold Rush Everyday Americans Dig for Fortune DuPont DD Slides 123 as Selling Pressure Mounts 20260518 Skilled Trades See 30 Pay Bump as College Career Path Fades Recruitment Giant CEO Says Lyft LYFT Climbs 072 Resistance at 1394 in Focus 20260520 Pantages Capital Acquisition Right PGACR Surges 16 Key Levels in Sight LeMaitre Vascular LMAT Unchanged at 10143 RangeBound Trading 20260520 Medantas Growth Strategy Established Hospitals Anchor NearTerm Performance Expansion Plans Underway Senco Gold Q4 Profit Surges 151 on Record Retail Sales and Soaring Gold Prices UK Intelligence Chief Warns West Faces Moment of Consequence from RussiaChina Threats US Productivity Growth Slows in Q4 as Labor Costs Rise Data Shows Geopolitical Tensions Escalate After Luhansk Strike Markets Weigh Risk AI Could Revolutionize Brain Drug Discovery Slashing Timelines from Decades to Years BillionToOne BLLN Q1 2026 Earnings Strong EPS Beat Overshadows Missing Revenue Details MRAM Q1 2026 Earnings Earnings Per Share Beats Analyst Estimates by 19 Global Self Storage Inc SELF Q4 2025 Earnings EPS Falls Short of Estimates as Revenue Details Remain Undisclosed SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue CRH Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Resilience Wall Street Opens Higher as Iran Tensions Ease Boosting Risk Appetite OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss Lite Strategy Inc LITS Q4 2024 Earnings Significant EPS Miss Amid Strategic Challenges GRWG Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amidst Market Challenges GWAV Q3 2023 Earnings Loss per Share Reported at 175 as Company Focuses on Operational Improvements SRE Q1 2026 Earnings Slight EPS Miss as Utility Performance Holds Steady QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies QFIN Q4 2025 Earnings Slight EPS Miss Amid Positive Stock Reaction CGNX Q1 2026 Earnings Robust EPS Surprise Overshadowed by Revenue Disappointment